Table 1.
Results of a pilot study to determine third ventricular injections of melanotan II (MTII) that do not increase interscapular brown adipose tissue (IBAT) temperature
| Dose | 1 h Postinjection | 2 h Postinjection | 3 h Postinjection | 4 h Postinjection | No. |
|---|---|---|---|---|---|
| Saline | 36.8±0.2 | 37.3±0.2 | 37.3±0.2 | 37.1±0.2 | 12 |
| MTII, 0.05 nmol | 37.0±0.6 | 37.1±0.8 | 37.0±0.3 | 36.9±0.4 | 4 |
| MTII, 0.10 nmol | 37.2±0.2 | 37.3±0.1 | 37.2±0.2 | 36.8±0.2 | 6 |
| MTII, 0.20 nmol | 37.2±0.2 | 37.3±0.5 | 37.5±0.4 | 37.2±0.1 | 3 |
| MTII, 0.30 nmol | 37.8±0.3 | 37.7±0.3 | 37.0±0.5 | 36.8±0.3 | 3 |
Note that we previously reported that third ventricular injections of 5 nmol MTII maximally stimulated IBAT temperature, with a smaller, but significant increase in IBAT temperature at 0.5 nmol (11); therefore, we began testing with doses lower than this latter dose.